Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pneumococcal Diseases”

563 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 563 results

Large-scale testing (Phase 3)Looking for participantsNCT06608199
What this trial is testing

Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Who this might be right for
Pneumococcal VaccinesPneumococcal Infections
Beijing Minhai Biotechnology Co., Ltd 500
Not applicableUnknownNCT04594785
What this trial is testing

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

Who this might be right for
Streptococcus PneumoniaStreptococcus Pyogenes InfectionNeisseria Meningitides Meningitis
University Hospital, Montpellier 150
Post-approval studies (Phase 4)Study completedNCT02787863
What this trial is testing

Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAsthmaPneumococcal Infections
Mikhael Petrovich Kostinov 219
Not applicableStudy completedNCT02126384
What this trial is testing

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response

Who this might be right for
Pneumococcal Diseases
Institut National de la Santé Et de la Recherche Médicale, France 9
Testing effectiveness (Phase 2)Study completedNCT02806284
What this trial is testing

Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery

Who this might be right for
Meningitis
Uppsala University 85
Large-scale testing (Phase 3)Study completedNCT02447432
What this trial is testing

Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 320
Large-scale testing (Phase 3)Study completedNCT04633226
What this trial is testing

Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)

Who this might be right for
Pneumococcal Disease
Merck Sharp & Dohme LLC 58
Early research (Phase 1)Study completedNCT00153543
What this trial is testing

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

Who this might be right for
Pneumococcal Infections
Centers for Disease Control and Prevention 86
Not applicableStudy completedNCT00195390
What this trial is testing

Study Investigating Administration of Prevenar for Post-Marketing Surveillance

Who this might be right for
Pneumococcal Infections
Wyeth is now a wholly owned subsidiary of Pfizer 600
Large-scale testing (Phase 3)Ended earlyNCT00119743
What this trial is testing

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

Who this might be right for
Hepatitis A
GlaxoSmithKline 5,000
Large-scale testing (Phase 3)Study completedNCT05158140
What this trial is testing

Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

Who this might be right for
Pneumococcal Infection
Merck Sharp & Dohme LLC 850
Post-approval studies (Phase 4)Study completedNCT04481243
What this trial is testing

Evaluate Pneumococcal Polysaccharide Vaccine Effectiveness in Children With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Mayo Clinic 29
Post-approval studies (Phase 4)Study completedNCT03489018
What this trial is testing

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Who this might be right for
Pneumococcal InfectionStreptococcus Pneumoniae InfectionInvasive Pneumococcal Disease, Protection Against
London School of Hygiene and Tropical Medicine 2,100
Large-scale testing (Phase 3)Study completedNCT00370396
What this trial is testing

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 1,200
Early research (Phase 1)Study completedNCT06562790
What this trial is testing

Study of Gamma PN3 in the Elderly

Who this might be right for
Pneumonia, Pneumococcal
GPN Vaccines 105
Large-scale testing (Phase 3)UnknownNCT01619462
What this trial is testing

Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children

Who this might be right for
PneumoniaMeningitisBacteraemia+2 more
Papua New Guinea Institute of Medical Research 200
Large-scale testing (Phase 3)Study completedNCT00035269
What this trial is testing

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Who this might be right for
Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
Pfizer 230
Early research (Phase 1)Not Yet RecruitingNCT07406347
What this trial is testing

A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06531538
What this trial is testing

Learn About How a New Pneumococcal Vaccine Works in Children

Who this might be right for
Pneumococcal Disease
Pfizer 225
Large-scale testing (Phase 3)Looking for participantsNCT07365826
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 1,300
Load More Results